Prime Medicine Inc (PRME)
$4.72 -9.92% Close Oct 30, 2026 Live
Prime Medicine stock today
Prime Medicine closed at $4.72 on October 30, 2026, down 9.92% on the day. Over the past year it returned +8.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $853 million.
$3.00$4.00$5.00
NovJan 2026MarMayJulSep
| Period | PRME | S&P 500 (SPY) |
|---|---|---|
| 1 month | +54.5% | -0.9% |
| 3 months | +56.3% | +2.1% |
| Year to date | +36.0% | +11.7% |
| 1 year | +8.5% | +12.4% |
| 3 years | -18.9% | +88.5% |
Key statistics
- Market value
- $853M
- Price / sales
- 209.4
- 52-week range
- $2.70 to $5.36
- Next report
- Nov 6, 2026 (estimated)
About Prime Medicine
Develops genetic medicines and cell therapy treatments for disease.
Sector: Health Care
More on Prime Medicine
- Financials: revenue, earnings and segmentsRevenue +55% in the year to Dec 2025
- Returns: what $1,000 became$1,000 three years ago is $811.00 today
No forecast, no recommendation. This page describes Prime Medicine Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.